Dupixent (dupilumab) is given by injection every two weeks. It was approved to treat patients with nasal polyps and chronic rhinosinusitis -- defined as a prolonged inflammation of the sinuses and nasal cavity, the FDA said.
from WebMD Health https://ift.tt/2Nhtb3r
0 comments:
Post a Comment